CALC Stock Price | CalciMedica, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

CalciMedica, Inc. Common Stock • CALC

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About CalciMedica, Inc. Common Stock

Ticker

CALC

Trading on

NASDAQ

ISIN

US38942Q2021

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. A. Rachel Leheny Ph.D.

Headquarters

505 Coast Boulevard South, La Jolla, CA, United States, 92037

Employees

Website

https://calcimedica.com

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.

Metrics

BasicAdvanced

Market cap

$27M

P/E ratio

EPS

-$1.22

Dividend Yield

0.00%

Beta

1.22

Forward P/E ratio

EBIDTA

$-24.1M

Ex dividend date

Price & volume

Market cap

$27M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

1.87

Earnings

EPS

-$1.22

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-24.1M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.22

52-week High

$6.02

52-week Low

$1.43

50-day moving average

$1.85

200-day moving average

$3.14

Short ratio

3.37

Short %

0.74%

Management effectiveness

ROE (TTM)

121.42%

ROA (TTM)

94.61%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

14M

Float

5.4M

Insiders %

16.98%

Institutions %

60.37%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$16.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.01

-$0.67

101.49%

Q1 • 24Beat

-$0.36

-$0.53

32.08%

Q2 • 24Beat

-$0.50

Q3 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-5.6M

∞%

Q3 • 24

$0M

$-4.3M

∞%

Q4 • 24

NaN%

24.21%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$16.2M

$7.2M

44.30%

Q3 • 24

$19.8M

$5.4M

27.20%

Q4 • 24

22.09%

25.03%

38.60%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-16.2M

$8.7M

$19.1M

$-16.2M

Q3 • 24

$-5M

$-5.2M

$8.9M

$-5M

Q4 • 24

69.26%

159.07%

53.17%

69.26%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a CalciMedica, Inc. Common Stock share?

CalciMedica, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does CalciMedica, Inc. Common Stock have?

CalciMedica, Inc. Common Stock currently has 14M shares.

Does CalciMedica, Inc. Common Stock pay dividends?

No, CalciMedica, Inc. Common Stock doesn't pay dividends.

What is CalciMedica, Inc. Common Stock 52 week high?

CalciMedica, Inc. Common Stock 52 week high is $6.02.

What is CalciMedica, Inc. Common Stock 52 week low?

CalciMedica, Inc. Common Stock 52 week low is $1.43.

What is the 200-day moving average of CalciMedica, Inc. Common Stock?

CalciMedica, Inc. Common Stock 200-day moving average is $3.14.

Who is CalciMedica, Inc. Common Stock CEO?

The CEO of CalciMedica, Inc. Common Stock is Dr. A. Rachel Leheny Ph.D..

How many employees CalciMedica, Inc. Common Stock has?

CalciMedica, Inc. Common Stock has 14 employees.

What is the market cap of CalciMedica, Inc. Common Stock?

The market cap of CalciMedica, Inc. Common Stock is $27M.

What is the P/E of CalciMedica, Inc. Common Stock?

The current P/E of CalciMedica, Inc. Common Stock is null.

What is the EPS of CalciMedica, Inc. Common Stock?

The EPS of CalciMedica, Inc. Common Stock is -$1.22.

What is the PEG Ratio of CalciMedica, Inc. Common Stock?

The PEG Ratio of CalciMedica, Inc. Common Stock is null.

What do analysts say about CalciMedica, Inc. Common Stock?

According to the analysts CalciMedica, Inc. Common Stock is considered a buy.